209 related articles for article (PubMed ID: 18801393)
1. The fate of the large striatal interneurons expressing calretinin in Huntington's disease.
Massouh M; Wallman MJ; Pourcher E; Parent A
Neurosci Res; 2008 Dec; 62(4):216-24. PubMed ID: 18801393
[TBL] [Abstract][Full Text] [Related]
2. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons.
Cicchetti F; Parent A
Mov Disord; 1996 Nov; 11(6):619-26. PubMed ID: 8914086
[TBL] [Abstract][Full Text] [Related]
3. Chemical phenotype of calretinin interneurons in the human striatum.
Cicchetti F; Beach TG; Parent A
Synapse; 1998 Nov; 30(3):284-97. PubMed ID: 9776132
[TBL] [Abstract][Full Text] [Related]
4. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
[TBL] [Abstract][Full Text] [Related]
5. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
Giampà C; DeMarch Z; D'Angelo V; Morello M; Martorana A; Sancesario G; Bernardi G; Fusco FR
Eur J Neurosci; 2006 Jan; 23(1):11-20. PubMed ID: 16420411
[TBL] [Abstract][Full Text] [Related]
6. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
Suzuki M; Desmond TJ; Albin RL; Frey KA
Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
[TBL] [Abstract][Full Text] [Related]
7. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
8. Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease.
Cicchetti F; Prensa L; Wu Y; Parent A
Brain Res Brain Res Rev; 2000 Nov; 34(1-2):80-101. PubMed ID: 11086188
[TBL] [Abstract][Full Text] [Related]
9. Neurogenesis and stereological morphometry of calretinin-immunoreactive GABAergic interneurons of the neostriatum.
Rymar VV; Sasseville R; Luk KC; Sadikot AF
J Comp Neurol; 2004 Feb; 469(3):325-39. PubMed ID: 14730585
[TBL] [Abstract][Full Text] [Related]
10. Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes.
Ariano MA; Wagle N; Grissell AE
J Neurosci Res; 2005 Jun; 80(5):634-45. PubMed ID: 15880743
[TBL] [Abstract][Full Text] [Related]
11. Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: an in situ hybridization study.
Holt DJ; Bachus SE; Hyde TM; Wittie M; Herman MM; Vangel M; Saper CB; Kleinman JE
Biol Psychiatry; 2005 Sep; 58(5):408-16. PubMed ID: 16023618
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.
Augood SJ; Faull RL; Emson PC
Ann Neurol; 1997 Aug; 42(2):215-21. PubMed ID: 9266732
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity.
Liang ZQ; Wang XX; Wang Y; Chuang DM; DiFiglia M; Chase TN; Qin ZH
Neurobiol Dis; 2005 Nov; 20(2):562-73. PubMed ID: 15922606
[TBL] [Abstract][Full Text] [Related]
14. The number of striatal cholinergic interneurons expressing calretinin is increased in parkinsonian monkeys.
Petryszyn S; Di Paolo T; Parent A; Parent M
Neurobiol Dis; 2016 Nov; 95():46-53. PubMed ID: 27388937
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic interneurons in the Q140 knockin mouse model of Huntington's disease: Reductions in dendritic branching and thalamostriatal input.
Deng YP; Reiner A
J Comp Neurol; 2016 Dec; 524(17):3518-3529. PubMed ID: 27219491
[TBL] [Abstract][Full Text] [Related]
16. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.
Capetian P; Knoth R; Maciaczyk J; Pantazis G; Ditter M; Bokla L; Landwehrmeyer GB; Volk B; Nikkhah G
Neuroscience; 2009 May; 160(3):661-75. PubMed ID: 19254752
[TBL] [Abstract][Full Text] [Related]
17. The calretinin interneurons of the striatum: comparisons between rodents and primates under normal and pathological conditions.
Petryszyn S; Parent A; Parent M
J Neural Transm (Vienna); 2018 Mar; 125(3):279-290. PubMed ID: 28168621
[TBL] [Abstract][Full Text] [Related]
18. Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease.
Cicchetti F; Gould PV; Parent A
Brain Res; 1996 Aug; 730(1-2):232-7. PubMed ID: 8883909
[TBL] [Abstract][Full Text] [Related]
19. Morphological features of neurons containing calcium-binding proteins in the human striatum.
Prensa L; Giménez-Amaya JM; Parent A
J Comp Neurol; 1998 Jan; 390(4):552-63. PubMed ID: 9450535
[TBL] [Abstract][Full Text] [Related]
20. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study.
Albin RL; Qin Y; Young AB; Penney JB; Chesselet MF
Ann Neurol; 1991 Oct; 30(4):542-9. PubMed ID: 1838677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
